Cadence Bank’s United Therapeutics UTHR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | $1.97M | Buy |
4,049
+140
| +4% | +$65.2K | 0.12% | 121 |
|
|
2025
Q3 | $1.64M | Hold |
3,909
| – | – | 0.1% | 133 |
|
|
2025
Q2 | $1.12M | Sell |
3,909
-54
| -1% | -$16.1K | 0.07% | 160 |
|
|
2025
Q1 | $1.22M | Buy |
3,963
+47
| +1% | +$16.1K | 0.09% | 144 |
|
|
2024
Q4 | $1.38M | Sell |
3,916
-29
| -0.7% | -$10.7K | 0.09% | 138 |
|
|
2024
Q3 | $1.41M | Sell |
3,945
-61
| -2% | -$20.6K | 0.1% | 142 |
|
|
2024
Q2 | $1.28M | Hold |
4,006
| – | – | 0.1% | 126 |
|
|
2024
Q1 | $920K | Buy |
4,006
+26
| +0.7% | +$5.87K | 0.07% | 164 |
|
|
2023
Q4 | $875K | Hold |
3,980
| – | – | 0.07% | 170 |
|
|
2023
Q3 | $899K | Hold |
3,980
| – | – | 0.08% | 155 |
|
|
2023
Q2 | $879K | Sell |
3,980
-49
| -1% | -$10.9K | 0.08% | 165 |
|
|
2023
Q1 | $902K | Sell |
4,029
-60
| -1% | -$14.8K | 0.08% | 158 |
|
|
2022
Q4 | $1.14M | Sell |
4,089
-25
| -0.6% | -$6.31K | 0.11% | 141 |
|
|
2022
Q3 | $861K | Hold |
4,114
| – | – | 0.09% | 153 |
|
|
2022
Q2 | $969K | Sell |
4,114
-134
| -3% | -$27.2K | 0.14% | 80 |
|
|
2022
Q1 | $762K | Sell |
4,248
-176
| -4% | -$33.5K | 0.09% | 105 |
|
|
2021
Q4 | $956K | Buy |
4,424
+11
| +0.2% | +$2.16K | 0.12% | 98 |
|
|
2021
Q3 | $815K | Buy |
4,413
+118
| +3% | +$23.2K | 0.11% | 106 |
|
|
2021
Q2 | $770K | Buy |
4,295
+101
| +2% | +$19.2K | 0.11% | 108 |
|
|
2021
Q1 | $702K | Buy |
4,194
+102
| +2% | +$17K | 0.11% | 114 |
|
|
2020
Q4 | $621K | Buy |
4,092
+28
| +0.7% | +$3.67K | 0.1% | 130 |
|
|
2020
Q3 | $410K | Hold |
4,064
| – | – | 0.08% | 132 |
|
|
2020
Q2 | $492K | Buy |
4,064
+7
| +0.2% | +$788 | 0.1% | 127 |
|
|
2020
Q1 | $385K | Buy |
4,057
+142
| +4% | +$13.5K | 0.1% | 125 |
|
|
2019
Q4 | $345K | Buy |
3,915
+112
| +3% | +$9.86K | 0.06% | 157 |
|
|
2019
Q3 | $303K | Sell |
3,803
-21
| -0.5% | -$1.69K | 0.03% | 185 |
|
|
2019
Q2 | $299K | Buy |
3,824
+97
| +3% | +$9.07K | 0.03% | 182 |
|
|
2019
Q1 | $437K | Sell |
3,727
-46
| -1% | -$5.36K | 0.04% | 157 |
|
|
2018
Q4 | $410K | Sell |
3,773
-307
| -8% | -$35.6K | 0.05% | 163 |
|
|
2018
Q3 | $522K | Buy |
4,080
+196
| +5% | +$24.2K | 0.05% | 155 |
|
|
2018
Q2 | $440K | Buy |
3,884
+397
| +11% | +$43.6K | 0.04% | 164 |
|
|
2018
Q1 | $392K | Buy |
3,487
+257
| +8% | +$32.6K | 0.04% | 170 |
|
|
2017
Q4 | $478K | Buy |
+3,230
| New | +$411K | 0.05% | 156 |
|
Other funds holding UTHR
ACA
